Filtravate
Las Cruces
About Filtravate
Filtravate is a membrane technology company that develops ultrafiltration membranes for applications in the bioprocessing and biopharmaceutical industries. Filtravate’s membranes have controlled and tunable pore size, even pore distribution, and functionalized surfaces. Based on patent-pending technology licensed from New Mexico State University (NMSU), Filtravate’s products provide significant anti-fouling and improved flux characteristics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (Apr 2021)
- Website: filtravate.com
- Phone: 479.571.2592
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/filtravate-173402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.